DWTX
Dogwood Therapeutics Inc.

7,042
Loading...
Loading...
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
12

Frequently Asked Questions

What is Market Cap of Dogwood Therapeutics Inc.?
What is the 52-week high for Dogwood Therapeutics Inc.?
What is the 52-week low for Dogwood Therapeutics Inc.?
What is Dogwood Therapeutics Inc. stock price today?
What was Dogwood Therapeutics Inc. stock price yesterday?
What is the PE ratio of Dogwood Therapeutics Inc.?
What is the Price-to-Book ratio of Dogwood Therapeutics Inc.?
What is the 50-day moving average of Dogwood Therapeutics Inc.?
How many employess does Dogwood Therapeutics Inc. has?

Latest DWTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.